These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 22215356)
1. Aztreonam lysine for inhalation: new formulation of an old antibiotic. Zeitler K; Salvas B; Stevens V; Brown J Am J Health Syst Pharm; 2012 Jan; 69(2):107-15. PubMed ID: 22215356 [TBL] [Abstract][Full Text] [Related]
2. Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine. Elborn JS; Henig NR Expert Opin Pharmacother; 2010 Jun; 11(8):1373-85. PubMed ID: 20426707 [TBL] [Abstract][Full Text] [Related]
8. Inhaled aztreonam lysine: an evidence-based review. Hutchinson D; Barclay M; Prescott WA; Brown J Expert Opin Pharmacother; 2013 Oct; 14(15):2115-24. PubMed ID: 23992352 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis. Hansen C; Skov M Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692 [TBL] [Abstract][Full Text] [Related]
10. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study. Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM; J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537 [TBL] [Abstract][Full Text] [Related]
12. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Retsch-Bogart GZ; Burns JL; Otto KL; Liou TG; McCoy K; Oermann C; Gibson RL; Pediatr Pulmonol; 2008 Jan; 43(1):47-58. PubMed ID: 18041081 [TBL] [Abstract][Full Text] [Related]
13. An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Oermann CM; Retsch-Bogart GZ; Quittner AL; Gibson RL; McCoy KS; Montgomery AB; Cooper PJ Pediatr Pulmonol; 2010 Nov; 45(11):1121-34. PubMed ID: 20672296 [TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI). Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; McKevitt M; Montgomery AB J Antimicrob Chemother; 2011 Oct; 66(10):2398-404. PubMed ID: 21784781 [TBL] [Abstract][Full Text] [Related]